(Q38025685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Drug interaction potential of resveratrol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Pascal Detampel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Mareike Beck

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Stephan Krähenbühl

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

published in

Drug Metabolism Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

253-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Inhibition of cancer growth by resveratrol is related to its low bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Grapefruit juice-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Bioequivalence revisited: influence of age and sex on CYP enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Qualitative and quantitative assessment of drug-drug interaction potential in man, based on Ki, IC50 and inhibitor concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol commonly displays hormesis: occurrence and biomedical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol is a selective human cytochrome P450 1A1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Dose adjustment in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Safety of resveratrol with examples for high purity, trans-resveratrol, resVida(®).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Contribution of intestinal cytochrome p450-mediated metabolism to drug-drug inhibition and induction interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Toxicogenomics of resveratrol in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Interaction between grapefruit juice and midazolam in humans*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Grapefruit juice substantially increases plasma concentrations of buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Sex-dependent metabolism of xenobiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Red wine-cisapride interaction: comparison with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Interaction between grapefruit juice and diazepam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Clinical trials of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Influence of lipophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Regioselective reactions for programmable resveratrol oligomer synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Effects of combined treatment with resveratrol and indole-3-carbinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Safety studies conducted on high-purity trans-resveratrol in experimental animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

The effects of green tea polyphenols on drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Cellular and molecular effects of resveratrol in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

Polymorphism of human cytochrome P450 enzymes and its clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.700715

10.3109/03602532.2012.700715

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788578%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference